about
A landscape of driver mutations in melanomaMutational heterogeneity in cancer and the search for new cancer-associated genesMelanoma genome sequencing reveals frequent PREX2 mutationsDiscovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingExome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerThe genomic complexity of primary human prostate cancerThe mutational landscape of head and neck squamous cell carcinomaRNF43 is frequently mutated in colorectal and endometrial cancersOncotator: cancer variant annotation tool.Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients.Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.Evolution and impact of subclonal mutations in chronic lymphocytic leukemiaComprehensive Molecular Characterization of Papillary Renal-Cell CarcinomaExome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexityPunctuated evolution of prostate cancer genomes.An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusionCharacterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients.Pan-cancer patterns of somatic copy number alteration.A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing eventsSomatic mutation of CDKN1B in small intestine neuroendocrine tumors.Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic PipelinesComprehensive Analysis of Alternative Splicing Across Tumors from 8,705 PatientsComprehensive Characterization of Cancer Driver Genes and MutationsThe Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell CarcinomaFramework For Quality Assessment Of Whole Genome, Cancer SequencesDiscovery and characterization of coding and non-coding driver mutations in more than 2,500 whole cancer genomesComprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
P50
Q24603357-2FA23666-3FBE-4B4F-85A2-01923F495163Q24606956-C7D4C9D3-11A0-489E-B78F-255037F51858Q24610463-C513EF3F-39FD-4FDA-AC62-259FF3F36C7BQ24612248-358E81BB-2705-41F8-94CF-9C2E9E3B091FQ24616117-CC7A7000-F125-4558-BC77-5070DD206CF8Q24617949-094BEFD5-31E5-4CCB-893E-E9BE6442F6C8Q29614654-7D28CB7F-991C-4E3F-9B88-BB67FBF63B17Q34817306-C622A418-2DED-48AF-A1D4-E485460F1424Q35565104-50851F8B-120D-43AB-958C-2CE9E4D98C5CQ36205151-D85FFA79-3386-46B6-AE08-C916748F0BCCQ36352133-6A9DCF50-75A5-4CC6-A410-4C787B6B9D0DQ36497294-900137C6-530D-4FC3-8433-9661A4FC73CDQ36619124-62E32206-14B3-4E3D-9860-54F4BFA3375FQ36642291-F8D2FC68-5A49-4681-87C9-1A5944DA4E82Q36918993-8A2F5A42-8BB4-43AE-9F1C-B86CC6BB7A85Q36950514-35995C7C-6173-4039-ACD2-96345CEED24AQ37211712-0E05B5C5-247A-40E0-98AC-DBEE51C13DA9Q37242449-F4AADD76-3ADF-4C4C-B93F-B8E6EF98DA9EQ37346462-DC02458D-520C-4769-8F7E-75534A515C9CQ37666205-A75D5562-F2FE-4605-ADE9-D15307D6869FQ39027040-E2A3DA25-8277-4097-A54F-3787E703FC56Q43018762-5DA1CFCA-EB00-4220-8C72-8373B5687D90Q56395203-990A28C7-185A-4AB0-BC5E-A2119AB8C78BQ57261157-8DFD62E6-9DBB-49D2-8544-80D409494F1FQ57261160-529884C6-E2D9-466B-AFAE-5FDE1326006CQ57261171-DC62EA46-C238-48E4-BBC3-7684D70B77BCQ57394756-0BABF433-6C0E-4F25-B32C-3F1D86676684Q57401134-049E6EF7-7B83-415D-A848-1B654AB52079Q57632333-2C3E0BC0-CED6-41B2-A15E-B954A043BE46
P50
description
onderzoeker
@nl
name
Gordon Saksena
@en
Gordon Saksena
@es
Gordon Saksena
@sl
type
label
Gordon Saksena
@en
Gordon Saksena
@es
Gordon Saksena
@sl
prefLabel
Gordon Saksena
@en
Gordon Saksena
@es
Gordon Saksena
@sl